Terbogrel

Terbogrel is a pharmacological agent that is classified as a thromboxane receptor antagonist and thromboxane synthase inhibitor. It is primarily used in the treatment of pulmonary arterial hypertension and other conditions that involve the overproduction of thromboxane.

Pharmacology

Terbogrel is a dual thromboxane receptor antagonist and thromboxane synthase inhibitor. This means that it works by blocking the action of thromboxane, a substance in the body that causes blood vessels to narrow and promotes clotting. By inhibiting the production and action of thromboxane, Terbogrel can help to widen blood vessels and prevent blood clots.

Clinical Uses

The primary use of Terbogrel is in the treatment of pulmonary arterial hypertension, a condition characterized by high blood pressure in the arteries that supply the lungs. By widening these arteries, Terbogrel can help to reduce blood pressure and improve symptoms.

In addition to pulmonary arterial hypertension, Terbogrel may also be used in the treatment of other conditions that involve the overproduction of thromboxane, such as coronary artery disease and peripheral artery disease.

Side Effects

Like all medications, Terbogrel can cause side effects. These may include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, Terbogrel may also cause more serious side effects, such as bleeding or bruising.

See Also

• Thromboxane receptor antagonist
• Thromboxane synthase inhibitor
• Pulmonary arterial hypertension
• Coronary artery disease
• Peripheral artery disease

Terbogrel Resources
Latest articles Most recent articles Ongoing trials	Wikipedia